Zacks Investment Research upgraded shares of LHC Group (NASDAQ:LHCG) from a hold rating to a buy rating in a research note published on Saturday morning. They currently have $67.00 price objective on the health services provider’s stock.

According to Zacks, “LHC Group provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States. They provide home-based services through their home nursing agencies and hospices and facility-based services through their long-term acute care hospitals and outpatient rehabilitation clinics. “

Several other research analysts have also weighed in on LHCG. Stephens set a $69.00 target price on LHC Group and gave the stock a buy rating in a research report on Saturday, May 6th. BidaskClub lowered LHC Group from a buy rating to a hold rating in a research report on Tuesday, July 25th. Benchmark Co. upped their target price on LHC Group from $63.00 to $72.00 and gave the stock a buy rating in a research report on Thursday, June 8th. Jefferies Group LLC reaffirmed a buy rating and issued a $65.00 target price on shares of LHC Group in a research report on Friday, June 9th. Finally, Royal Bank Of Canada reaffirmed a buy rating on shares of LHC Group in a research report on Tuesday, June 13th. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. LHC Group presently has a consensus rating of Buy and a consensus price target of $65.75.

LHC Group (NASDAQ LHCG) opened at 63.95 on Friday. The stock has a 50 day moving average price of $64.12 and a 200 day moving average price of $56.24. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of 28.30 and a beta of 0.77. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $260.20 million for the quarter, compared to analyst estimates of $254.10 million. During the same period in the prior year, the firm posted $0.52 EPS. The business’s revenue was up 15.1% compared to the same quarter last year. Analysts predict that LHC Group will post $2.39 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/09/lhc-group-lhcg-lifted-to-buy-at-zacks-investment-research.html.

In other news, Director Coliseum Capital Management, L sold 8,632 shares of the company’s stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.25, for a total transaction of $520,078.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the sale, the chief operating officer now owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last quarter, insiders have sold 682,839 shares of company stock valued at $42,140,531. 14.80% of the stock is currently owned by corporate insiders.

Hedge funds have recently added to or reduced their stakes in the company. Federated Investors Inc. PA increased its stake in LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares during the period. First Mercantile Trust Co. bought a new stake in LHC Group during the second quarter valued at about $147,000. Invictus RG bought a new stake in LHC Group during the first quarter valued at about $125,000. US Bancorp DE increased its stake in LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares during the period. Finally, State of Alaska Department of Revenue increased its stake in LHC Group by 79.1% in the second quarter. State of Alaska Department of Revenue now owns 2,955 shares of the health services provider’s stock valued at $200,000 after buying an additional 1,305 shares during the period. Institutional investors own 84.97% of the company’s stock.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Get a free copy of the Zacks research report on LHC Group (LHCG)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.